Substituted pyrazole and triazole compounds as KSP inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S266200, C548S267200

Reexamination Certificate

active

07902240

ABSTRACT:
Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof:

REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5023252 (1991-06-01), Hseih et al.
patent: 5185450 (1993-02-01), Owen
patent: 6545004 (2003-04-01), Finer et al.
patent: 6562831 (2003-05-01), Finer et al.
patent: 6630479 (2003-10-01), Finer et al.
patent: 2005/0228002 (2005-10-01), Wang et al.
patent: 2005/0261337 (2005-11-01), Wang et al.
patent: 2006/0084687 (2006-04-01), Boyce et al.
patent: 2007/0037853 (2007-02-01), Barsanti et al.
patent: 2007/0270473 (2007-11-01), Saunders et al.
patent: WO 00/59887 (2000-10-01), None
patent: WO 01/30768 (2001-05-01), None
patent: WO 02/28839 (2002-04-01), None
patent: WO 02/056880 (2002-07-01), None
patent: WO 02/057244 (2002-07-01), None
patent: WO 03/039460 (2003-05-01), None
patent: WO 03/043995 (2003-05-01), None
patent: WO 03/049527 (2003-06-01), None
patent: WO 03/049678 (2003-06-01), None
patent: WO 03/049679 (2003-06-01), None
patent: WO 03/050064 (2003-06-01), None
patent: WO 03/050122 (2003-06-01), None
patent: WO 03/059289 (2003-07-01), None
patent: WO 03/070701 (2003-08-01), None
patent: WO 03/079973 (2003-10-01), None
patent: WO 03/094839 (2003-11-01), None
patent: WO 03/097053 (2003-11-01), None
patent: WO 03/099211 (2003-12-01), None
patent: WO 03/103575 (2003-12-01), None
patent: WO 03/105855 (2003-12-01), None
patent: WO 03/106417 (2003-12-01), None
patent: WO 2004/004652 (2004-01-01), None
patent: WO 2004/006865 (2004-01-01), None
patent: WO 2004/009036 (2004-01-01), None
patent: WO 2004/018058 (2004-03-01), None
patent: WO 2004/024086 (2004-03-01), None
patent: WO 2004/026226 (2004-04-01), None
patent: WO 2004/100873 (2004-11-01), None
patent: WO 2004/103282 (2004-12-01), None
patent: WO 2006/002236 (2006-01-01), None
U.S. Appl. No. 11/969,164, filed Jan. 3, 2008, Boyce et al.
Blangy, A. et al., “Phosphorylation by p34cdc2Regulates Spindle Assoication of Human Eg5, a Kinesin-Related Motor Essential for Bipolar Spindle Formation In Vivo”,Cell83:1159-1169, 1995.
Coleman, P.J. et al., “Inhibitors of the Mitotic Kinesin Spindle Protein”. Expert Opinion on Therapeutic Patents, Ashely Publications, 14(12):1659-1668, 2004.
Debonis, S., et al., “Interaction of the Mitotic Inhibitor Monastrol With Human Kinesin EG5”.Biochemistry, 2003, 42:338-349.
Enos, A.P. et al. “Mutation of a Gene That Encodes a Kinesin-like Protein Blocks Nuclear Division in A. nidulans”.Cell60:1019-1027, 1990.
Giet, R., et al., “TheXenopus laevis Aurora-related Protein kinase pEg2 Associates with and Phosphorylates the Kinesin-related Protein XIEg5”.J. Biol. Chem. 274(21):15005-15013, 1999.
Hagan, I. et al., “Novel Potential Mitotic Motor Protein Encoded by the Fission YeastCut7+ Gene”.Nature347:563-566, 1990.
Kaiser, A., et al., “All-trans-Retinoic Acid-mediated Growth Inhibition Involves Inhibition of Human Kenesin-related Protein HsEg5”.J. Biol. Chem. 274(27):18925-18931, 1999.
Kapoor, T.M., et al., “Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5”.J. Cell Biol., 150(5):975-988, 2000.
Mayer, T.U., et al., “Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen”.Science 286:971-974, 1999.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted pyrazole and triazole compounds as KSP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazole and triazole compounds as KSP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazole and triazole compounds as KSP inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2725744

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.